Priority Date: 06.01.12 (US 201261583885P)

USE OF GALECTIN-3 FOR RISK ASSESSMENT AND DETECTION OF PREECLAMPSIA AND RELATED CONDITIONS

  • Application ID: EP13701684
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Attorney

Employment test 11 - 50 employees
Company dna eip1
operating since 2009
1104.09
Headquarter in London and 4 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC class G01 (MEASURING; TESTING). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 06.01.2012 - Priority Date (US 201261583885P)
  • 11.07.2013 - Publication A2 (WO2013103984)
  • 12.11.2014 - Publication A2 (EP2800976)

IPC Classification